Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

The quiet crisis: why medicines operations matter more than ever in the ICB era

July 4, 2025 Business Services, Market Access Gateway to Local Adoption, Integrated Care Board, NHS, Primary Care Networks, Visions4Health

In the second of the Gateway to Local Access series, Vision4Health caught up with Dr Graham Duce, ICB GP Prescribing …
Feature

Biocon Biologics gains EU approval for bone health therapies

July 4, 2025 Market Access, Medical Communications, Research and Development Biocon Biologics, Committee for Medicinal Products for Human USE, European Commission, Evfraxy, Oncology, Orthopaedics, Osteoporosis, Vevzuo, bone health, osteoporosis, prostate cancer

Biocon Biologics has announced that the European Commission has granted marketing authorisation for its denosumab biosimilars, Vevzuo and Evfraxy, marking …
News

Unlocking the gateway to ‘precision’ UK market access

June 27, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …
Feature
Thought Leadership

CSL Behring’s therapy for hereditary angioedema receives positive assessment in Germany

June 26, 2025 Market Access, Market Research, Medical Communications, Research and Development, Sales and Marketing CSL Behring, Institute for Quality and Efficiency in Health Care, Rare Diseases, clinical trials, hereditary angioedema, market access

CSL Behring has announced a key milestone for its hereditary angioedema (HAE) therapy, garadacimab, following a positive benefit assessment by …
News
handshake_2

AOTI achieves broad market access in Germany for diabetic foot ulcer therapy

June 23, 2025 Market Access, Medical Communications, Sales and Marketing AOTI, Diabetes, European pharma market, German pharma market, Wound Healing, diabetic foot ulcers, market access, positive recommendation

AOTI, focused on solutions for severe and chronic wounds, has announced that its unique topical wound oxygen (TWO2) therapy has …
News

PM Society and CIM launch new leadership programme for pharma marketers

June 13, 2025 Sales and Marketing CIM Fellowship, Chartered Institute of Marketing (CIM), Corporate, Marketing Excellence Industry Group, PM Society Awards, Pharmaceutical Marketing (PM) Society, Pharmacy, partnership

The Pharmaceutical Marketing (PM) Society has partnered with the Chartered Institute of Marketing (CIM) to launch the PMS & CIM …
News

Treatment for serious eye disease approved in Scotland

June 12, 2025 Market Access, Marketing Services, Research and Development, Sales and Marketing LYTENAVA, Opthalmology, Scottish Medicines Consortium, clinical programme, european union, eye disease, market approval, strategic partnership, united kingdom, wet age-related macular degeneration

Outlook Therapeutics has announced the Scottish Medicines Consortium (SMC) approval of Lytenava (bevacizumab gamma) for the treatment of wet age-related …
News
cellectis

PEPperPRINT launches new peptide microarray platform on 15th anniversary

June 11, 2025 Biotech/start-up, Research and Development, Sales and Marketing Devices, PEPperPRINT, biotech research, peptide microarray platform

German biotech PEPperPRINT has marked its 15th anniversary with the launch of a new peptide microarray platform, combinatorial laser-induced forward …
News

Meteor Biotech opens site at UCLA to support biotech research

June 11, 2025 Biotech/start-up, Research and Development, Sales and Marketing Devices, Immunology, Meteor Biotech, Oncology, Pharmacy, University of California Los Angeles, cell sorting technology, clinical trials, research facility

South Korean spatial omics specialist, Meteor Biotech, has announced the opening of its first international office at the California NanoSystems …
News

Hansa Biopharma to host investor event on Guillain-Barré Syndrome to accelerate research

June 10, 2025 Conferencing, Events & Incentives, Interactive Conferences, Medical Communications, Research and Development, Sales and Marketing Guillain-Barré syndrome, Hansa Biopharma, Immunology, Neurology, investor event

Hansa Biopharma (Hansa) will host a virtual investor event on Guillain-Barré syndrome (GBS) on 16 June 2025. The webcast aims …
News

The unbearable lightness of creativity

June 9, 2025 Medical Communications, Sales and Marketing 21GRAMS, Atomic Matter, Corporate, HAVAS LYNX, London UK, PM Society Awards, Pharmacy, pharma healthcare communications, pharma marketing

21GRAMS and Havas Lynx lead the charge at the PM Society Awards for pharma marketing and healthcare communications Commenting on …
Feature

Orientation Marketing appoints Sarah Darcy as sales operations executive

May 27, 2025 Marketing Services, Sales and Marketing Corporate, pharmaceutical marketing agency, sales operations executive

Orientation Marketing has announced the appointment of Sarah Darcy as sales operations executive. She joins the business-to-business (B2B) life sciences and …
Appointment

MC2 Therapeutics appoints Trine Ahlgreen as new CEO

May 27, 2025 Research and Development, Sales and Marketing CEO, Corporate, MC2 Therapeutics, Skin, inflammatory skin conditions

MC2 Therapeutics, a Danish pharma company focused on topical therapies for inflammatory skin conditions, has appointed Trine Ahlgreen as CEO. …
Appointment

NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS

May 22, 2025 Market Access, Research and Development Haematology, Hympavzi, NHS, NICE, Pfizer, haemophilia B, marstacimab

Walton Oaks, 21st May 2025 – Pfizer Ltd announced today that the National Institute for Health and Care Excellence (NICE) has published final …
News
Press release

Multiple myeloma treatment approved in Japan

May 21, 2025 Market Access, Research and Development, Sales and Marketing GSK, Japan, Oncology, Orphan Drug Designation (ODD), multiple myeloma

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by Japan’s Ministry of Health, Labour and Welfare for the treatment of …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025